Malin Corporation | MLC - أصول متداولة





أصول متداولة تغيير تاريخ
Akebia Therapeutics USD 252.96M 5.38M 2025-12
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
ALKERMES USD 1.93B 187.5M 2025-12
Avita Medical AUD 35.49M 760K 2025-12
Dianthus Therapeutics USD 409.44M 4.39M 2025-12
Eurofins Scientific SE EUR 2.65B 34.2M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
IQVIA Holdings USD 6.25B 270M 2025-12
Lonza CHF 5.44B 113M 2024-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Moderna USD 6.54B 54M 2025-12
Organon & Co USD 4.7B 82M 2025-09
Ovoca Bio EUR 4.96M 2.06M 2022-06
Revvity USD 2.24B 95.96M 2025-12
Tectonic Therapeutic USD 273.24M 17.61M 2025-09
Viatris USD 9.79B 162.2M 2025-12
Xeris Pharmaceuticals USD 224.02M 38.44M 2025-09